As healthcare professionals ourselves, we understand the importance of quality scientific research. We are committed to ensuring EVA meets the highest standards of academic and clinical merit.
Click on the icons to access source documents, manuscripts, and publications in their original, unedited form!
EVA's modest first prototype was built in our founders' apartment. We tested our original facial recognition and fall prediction capabilities on family and friends in our own bedrooms.
EVA's Phase 1, pre-clinical study to determine efficacy (sensitivity/specificity) was conducted using 24 healthy volunteers in a simulated clinical setting at the University of Virginia School of Nursing.
UVA IRB-HSR: 15778
The three main stakeholders for EVA technologies are: (1) patients and families, (2) nurses and caregivers, (3) healthcare administration personnel. Our team interviewed dozens of these stakeholders to understand their specific needs.